ViaDerma, Inc.
VDRM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $600 | $541 | $514 | $11 |
| % Growth | 11.1% | 5.2% | 4,382.1% | – |
| Cost of Goods Sold | $0 | $0 | $3 | $1 |
| Gross Profit | $600 | $540 | $511 | $11 |
| % Margin | 100% | 100% | 99.5% | 94.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $415 | $295 | $183 | $82 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $415 | $295 | $183 | $82 |
| Operating Income | $185 | $245 | $328 | -$71 |
| % Margin | 30.9% | 45.4% | 63.8% | -616.2% |
| Other Income/Exp. Net | -$181 | $345 | -$1,322 | -$361 |
| Pre-Tax Income | $4 | $591 | -$994 | -$432 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $4 | $591 | -$994 | -$432 |
| % Margin | 0.7% | 109.3% | -193.4% | -3,764.2% |
| EPS | 0 | 0.001 | -0.001 | -0.001 |
| % Growth | -100% | 160% | -66.7% | – |
| EPS Diluted | 0 | 0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 1,177,573 | 983,556 | 966,750 | 770,508 |
| Weighted Avg Shares Out Dil | 1,686,916 | 983,556 | 966,750 | 770,508 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $76 | $99 | $111 | $149 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $81 | $690 | -$883 | -$283 |
| % Margin | 13.4% | 127.6% | -171.8% | -2,464.3% |